Pixium Vision - Second Sight $28m financing adds clouds to deal
On 24 March, Second Sight announced a $27.9m private placement (4.65m shares at $6.00/share), expected to close on 26 March. Such a capital raise was prohibited under the terms of the January 2021 memorandum of understanding (MOU) entered into by Pixium and Second Sight relating to the proposed business combination of both entities. Second Sight had requested Pixium’s prior consent in recent days but Pixium’s board declined, as it felt that due to regulatory constraints, the proposed private placement would jeopardise the likeliness of the closing of the $25m capital increase contemplated as one of the conditions required under the MOU for the business combination. Pixium is now seeking further information from Second Sight on the conditions of the private placement and will also study alternative financing solutions as appropriate, and intends to announce its next steps in the coming days.Pixium Vision SA is a company that specializes in sensorial neuromodulation. Co. is also collaborating with scientific groups and clinicians at research institutes and clinical centers around the world, including Stanford University (USA). Co. is developing and aims to commercialize Bionic Vision Systems (BVS) – namely active implantable medical devices to treat blindness caused by degeneration of photoreceptor cells in the retina.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.